KEY RATIOS NASDAQCRIS Price & Volume RECENT PRICE $4.84 52 WEEK HIGH $17.40 52 WEEK LOW $1.09 AVERAGE VOLUME (30 DAYS) 1.83M BETA 2.80 Share Related Items MARKET CAP $443.39M SHARES OUTSTANDING 91.61M FLOAT 91.37M Dividend Information YIELD % -- ANNUAL DIVIDEND -- PAYOUT RATIO -163.9% Financial Strength QUICK RATIO (MRQ) 13.9 CURRENT RATIO (MRQ) 14.2 LT DEBT/CAPITAL (MRQ) 4% TOTAL DEBT/EQUITY (MRQ) 5% Valuation Ratios PRICE/EARNINGS (TTM) (11.60) PRICE/SALES (TTM) 42.08 PRICE/BOOK (MRQ) 4.54 PRICE/CASH FLOW (TTM) -- Per Share Data EARNINGS (TTM) ($0.44) SALES (TTM) $0.12 BOOK VALUE (MRQ) $1.12 CASH FLOW (TTM) ($0.41) CASH (MRQ) $1.41 Management Effectiveness RETURN ON EQUITY (TTM) -105.4% RETURN ON ASSETS (TTM) -36.2% RETURN ON INVESTMENT (TTM) -79.8% Profitability GROSS MARGIN (TTM) 95.0% EBIT MARGIN (TTM) -329.5% PROFIT MARGIN (TTM) -- Currency in USD. Quote data delayed by at least 15 minutes. © Curis, Inc. 2019 - All Rights Reserved Terms of UsePrivacy Policy , in accordance with our privacy policies. I Understand

ABOUT CLINICAL STUDIES What are clinical studies? Clinical studies are scientific studies which seek to find better ways to understand and provide therapies to treat disease in certain groups of people. Clinical studies produce data which is used to make decisions about health care therapies. Clinical study benefits and risks: What are the potential benefits and risks of taking part in a clinical study? The potential benefits and risks are reviewed thoroughly with patients through an Informed Consent process and may include the following: Potential study benefits: Patients may gain access to an investigational drug before it is available to everyone. Patients may play a more active role in their own health care. Researchers may provide patients with medical care and more frequent health check-ups as part of their participation in the study. Patients may have the chance to help others get better therapies for their health problems in the future. Potential study risks: The investigational drug may cause side effects. The investigational drug may not be effective. The investigational drug may not be better than standard treatment. There may be other risks which are reviewed with patients during the consenting process. © Curis, Inc. 2021 - All Rights Reserved Terms of Use Privacy Policy , in accordance with our privacy policies. I Understand ABOUT COLLABORATIONS PATIENTS PIPELINE INVESTORS CAREERS CONTACT